Determination of the enantiomeric composition of a new insulin sensitizer in plasma samples from non-clinical and clinical investigations using chiral HPLC with electrospray tandem mass spectrometric detection

スポンサーリンク

概要

• 論文の詳細を見る
• 2006-05-01

著者

• Lausecker B.

  F. Hoffmann-la Roche Ltd. Pharmaceuticals Division Non-clinical Drug Safety

• Lausecker B.

  F. Hoffmann-la Roche Ltd. Pharmaceuticals Division Department Of Drug Metabolism And Pharmacokinetic

• FISCHER G.

  F. Hoffmann-La Roche Ltd., Pharmaceuticals Division, Non-Clinical Drug Safety

• Fischer G.

  F. Hoffmann-la Roche Ltd. Pharmaceuticals Division Non-clinical Drug Safety

関連論文

• Capillary electrophoresis-mass spectrometry coupling versus micro-high-performance liquid chromatography-mass spectrometry coupling : a case study
• Determination of the enantiomeric composition of a new insulin sensitizer in plasma samples from non-clinical and clinical investigations using chiral HPLC with electrospray tandem mass spectrometric detection

スポンサーリンク